Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of vonoprazan fumarate injection for peptic ulcer bleeding
ChiCTR2500096397Phase 2Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of vonoprazan in Peptic ulcer disease (PUD) (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Rebleeding rate. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
vonoprazan
03
Conditions
Peptic ulcer disease (PUD)
Beyond the preview
Go deeper on ChiCTR2500096397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096397.